Pos-COVID-19 syndrome: We only know how little we know

Article Sidebar

PDF (Spanish)
Published: 2021-12-30
DOI: https://doi.org/10.51987/revhospitalbaires.v41i4.130
Keywords:
long covid-19, post-acute sequelaeof covid-19, covid-19, covid recovery, covid-19 symptoms, post-covid-19 syndrome, post-acute covid

Main Article Content

Joaquín Maritano Furcada
Sección de Neumonología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina

Abstract

Patients who underwent COVID-19 can develop persisting symptoms and sequelae. Severe cases may exhibit systemic complications of critical care and/or inflammatory/fibrotic lung injury. Imaging and respiratory function tests can assist in the evaluation of both. Nonsevere cases can also develop persisting symptoms for more than 28 days, which has been defined as the post COVID-19 syndrome. The most common symptoms in said syndrome are fatigue, headache and dyspnea, which can last for months. Its course can be oscillating or even increase progressively within the first months. The considerable range of symptoms requires proper patient assessment. Post-infectious immune disregulation is believed to be the source of this syndrome. Proper assessment and followup warrant measured symptom management and emphatic care by the attending physician.

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 41 No. 4 (2021): Revista del Hospital Italiano de Buenos Aires

Section

Update and advances in research
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Maritano Furcada J. Pos-COVID-19 syndrome: We only know how little we know. Rev Hosp Ital B.Aires [Internet]. 2021 Dec. 30 [cited 2026 Jun. 6];41(4):p. 201-205. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/130

References

- Carfì A, Bernabei R, Landi F; et al. Persistent symptoms in patients after ccute COVID-19. JAMA. 2020;324(6):603-605. https://doi.org/10.1001/jama.2020.12603. DOI: https://doi.org/10.1001/jama.2020.12603

- Davis HE, Assaf GS, McCorkell L,et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. https://doi.org/10.1016/j.eclinm.2021.101019. DOI: https://doi.org/10.1016/j.eclinm.2021.101019

- Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(4):2003690. https://doi.org/10.1183/13993003.03690-2020. DOI: https://doi.org/10.1183/13993003.03690-2020

- Havervall S, Rosell A, Phillipson M, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015-2016. https://doi.org/10.1001/jama.2021.5612. DOI: https://doi.org/10.1001/jama.2021.5612

- Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232. https://doi.org/10.1016/S0140-6736(20)32656-8. DOI: https://doi.org/10.1016/S0140-6736(20)32656-8

- Lerum TV, Aaløkken TM, Brønstad E, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57(4):2003448. https://doi.org/10.1183/13993003.03448-2020. DOI: https://doi.org/10.1183/13993003.03448-2020

- Naidu SB, Shah AJ, Saigal A, et al. The high mental health burden of "Long COVID" and its association with on-going physical and respiratory symptoms in all adults discharged from hospital. Eur Respir J. 2021;57(6):2004364. https://doi.org/10.1183/13993003.04364-2020. DOI: https://doi.org/10.1183/13993003.04364-2020

- Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. https://doi.org/10.1038/s41591-021-01283-z. DOI: https://doi.org/10.1038/s41591-021-01283-z